Rapid Tests Market by Product (Over-the-Counter [OTC] Rapid Test Product and Professional Rapid Test Product), Application (Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others), and End User (Hospital & Clinic, Diagnostic Laboratory, Home Care, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

May 2018 | 235 pages | ID: R8FBD26B75BEN
Allied Market Research

Abstracts

The global rapid tests market generated $21,455 million in 2016, and is projected to reach $39,103 million by 2023, growing at a CAGR of 8.9% from 2017 to 2023. Rapid tests are diagnostic assays designed for use where preliminary screening tests need to be conducted. These tests are easy, quick, and provide specific results; hence, are used in settings with limited resources. Rapid tests are incorporated in diagnosis of different diseases and health conditions such as HIV, influenza, malaria, cancer, pregnancy & fertility, and others.
The rapid tests market is expected to grow at a significant rate during the forecast period, owing to increase in awareness regarding early diagnosis of disease, prevalence of infectious diseases, and need for low cost as well as accurate diagnostic testing. In addition, growth in personalized care and increased promotional activities by manufacturers encourage the usage rapid tests, which further facilitate the growth of the market. However, stringent government regulations for the approval of rapid tests and recall of several products due to false results are expected to impede the market growth.
The global rapid tests market is segmented based on product, application, end user, and region. Based on product, the market is bifurcated into over-the-counter (OTC) rapid test product and professional rapid test product. By application, the market is classified into infectious disease, cardiology, oncology, pregnancy & fertility, toxicology, glucose monitoring, and others. According to end user, it is segmented as hospital & clinic, diagnostic laboratory, home care, and others. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Comprehensive analysis of all geographical regions is provided to determine the existing opportunities.
• The profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product

• Over-the-counter (OTC) Rapid Test Product
• Professional Rapid Test Product

By Application

• Infectious Disease
• HPV
• Hepatitis
• Influenza
• Malaria
• HIV
• Others
• Cardiology
• Oncology
• Pregnancy & Fertility
• Toxicology
• Glucose Monitoring
• Others

By End User

• Hospital & Clinic
• Diagnostic Laboratory
• Home Care
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Akers Biosciences, Inc.
• Alere Inc. (Abbott Laboratories)
• Becton, Dickinson and Company
• Bio-rad Laboratories, Inc.
• Cepheid, Inc.
• Hologic, Inc.
• Meridian Bioscience, Inc.
• OraSure Technologies, Inc.
• Quidel Corporation
• Roche Diagnostics

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

• Abingdon Health
• ARKRAY, Inc.
• Biocom Diagnostics
• Biomerica, Inc.
• Demeditec Diagnostics GmbH
• Epitope Diagnostics Inc.
• NanoRepro AG.
• Randox Laboratories Ltd.

Contents

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
  1.3.1. List of key players profiled in the report
1.4. Research methodology
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
  2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
  3.2.1. Top investment pockets
3.3. Top player positioning
3.4. MARKET DYNAMICS
  3.4.1. Drivers
    3.4.1.1. Benefits of rapid tests over laboratory testing
    3.4.1.2. Increase in initiatives of government and nonprofit organizations towards health awareness
    3.4.1.3. Increase in healthcare expenditure worldwide
  3.4.2. Restraint
    3.4.2.1. Inadequate reimbursement policies for rapid test diagnostics
  3.4.3. Opportunities
    3.4.3.1. Growth opportunities in the emerging markets
    3.4.3.2. Increase in prevalence of various chronic and infectious diseases across the world
  3.4.4. Impact analysis

CHAPTER 4: RAPID TESTS MARKET, BY PRODUCT

4.1. Overview
  4.1.1. Market size and forecast
4.2. Over-the-counter (OTC) rapid test products
  4.2.1. Key market trends, growth factors, and opportunities
  4.2.2. Market size and forecast, by region
  4.2.3. Market analysis, by country
4.3. Professional rapid test products
  4.3.1. Key market trends, growth factors, and opportunities
  4.3.2. Market size and forecast, by region
  4.3.3. Market analysis, by country

CHAPTER 5: RAPID TESTS MARKET, BY APPLICATION

5.1. Overview
  5.1.1. Market size and forecast
5.2. Infectious disease
  5.2.1. Market size and forecast, by type
    5.2.1.1. HPV rapid tests
      5.2.1.1.1. Market size and forecast
    5.2.1.2. Hepatitis rapid tests
      5.2.1.2.1. Market size and forecast
    5.2.1.3. Influenza rapid tests
      5.2.1.3.1. Market size and forecast
    5.2.1.4. Malaria rapid tests
      5.2.1.4.1. Market size and forecast
    5.2.1.5. HIV rapid tests
      5.2.1.5.1. Market size and forecast
    5.2.1.6. Other infectious disease rapid tests
      5.2.1.6.1. Market size and forecast
  5.2.2. Market size and forecast, by region
  5.2.3. Market analysis, by country
5.3. Cardiology
  5.3.1. Market size and forecast
  5.3.2. Market analysis, by country
5.4. Oncology
  5.4.1. Market size and forecast
  5.4.2. Market analysis, by country
5.5. Pregnancy & fertility
  5.5.1. Market size and forecast
  5.5.2. Market analysis, by country
5.6. Toxicology
  5.6.1. Market size and forecast
  5.6.2. Market analysis, by country
5.7. Glucose monitoring
  5.7.1. Market size and forecast
  5.7.2. Market analysis, by country
5.8. Other applications
  5.8.1. Market size and forecast
  5.8.2. Market analysis, by country

CHAPTER 6: RAPID TESTS MARKET, BY END USER

6.1. Overview
  6.1.1. Market size and forecast
6.2. Hospitals & clinics
  6.2.1. Market size and forecast
  6.2.2. Market analysis, by country
6.3. Diagnostic laboratories
  6.3.1. Market size and forecast
  6.3.2. Market analysis, by country
6.4. Home care
  6.4.1. Market size and forecast
  6.4.2. Market analysis, by country
6.5. Others
  6.5.1. Market size and forecast
  6.5.2. Market analysis, by country

CHAPTER 7: RAPID TESTS MARKET, BY REGION

7.1. Overview
  7.1.1. Market size and forecast
7.2. North America
  7.2.1. Key market trends, growth factors, and opportunities
  7.2.2. Market size and forecast, by country
    7.2.2.1. U.S.
      7.2.2.1.1. U.S. rapid tests market, by product
      7.2.2.1.2. U.S. rapid tests market, by application
      7.2.2.1.3. U.S. rapid tests market, by end user
    7.2.2.2. Canada
      7.2.2.2.1. Canada rapid tests market, by product
      7.2.2.2.2. Canada rapid tests market, by application
      7.2.2.2.3. Canada rapid tests market, by end user
    7.2.2.3. Mexico
      7.2.2.3.1. Mexico rapid tests market, by product
      7.2.2.3.2. Mexico rapid tests market, by application
      7.2.2.3.3. Mexico rapid tests market, by end user
  7.2.3. North America rapid tests market, by product
  7.2.4. North America rapid tests market, application
  7.2.5. North America rapid tests market, by end user
7.3. Europe
  7.3.1. Key market trends, growth factors, and opportunities
  7.3.2. Market size and forecast, by country
    7.3.2.1. Germany
      7.3.2.1.1. Germany rapid tests market, by product
      7.3.2.1.2. Germany rapid tests market, by application
      7.3.2.1.3. Germany rapid tests market, by end user
    7.3.2.2. France
      7.3.2.2.1. France rapid tests market, by product
      7.3.2.2.2. France rapid tests market, by application
      7.3.2.2.3. France rapid tests market, by end user
    7.3.2.3. UK
      7.3.2.3.1. UK rapid tests market, by product
      7.3.2.3.2. UK rapid tests market, by application
      7.3.2.3.3. UK rapid tests market, by end user
    7.3.2.4. Italy
      7.3.2.4.1. Italy rapid tests market, by product
      7.3.2.4.2. Italy rapid tests market, by application
      7.3.2.4.3. Italy rapid tests market, by end user
    7.3.2.5. Spain
      7.3.2.5.1. Spain rapid tests market, by product
      7.3.2.5.2. Spain rapid tests market, by application
      7.3.2.5.3. Spain rapid tests market, by end user
    7.3.2.6. Rest of Europe
      7.3.2.6.1. Rest of Europe rapid tests market, by product
      7.3.2.6.2. Rest of Europe rapid tests market, by application
      7.3.2.6.3. Rest of Europe rapid tests market, by end user
  7.3.3. Europe rapid tests market, by product
  7.3.4. Europe rapid tests market, application
  7.3.5. Europe rapid tests market, by end user
7.4. Asia-Pacific
  7.4.1. Key market trends, growth factors, and opportunities
  7.4.2. Market size and forecast, by country
    7.4.2.1. Japan
      7.4.2.1.1. Japan rapid tests market, by product
      7.4.2.1.2. Japan rapid tests market, by application
      7.4.2.1.3. Japan rapid tests market, by end user
    7.4.2.2. China
      7.4.2.2.1. China rapid tests market, by product
      7.4.2.2.2. China rapid tests market, by application
      7.4.2.2.3. China rapid tests market, by end user
    7.4.2.3. Australia
      7.4.2.3.1. Australia rapid tests market, by product
      7.4.2.3.2. Australia rapid tests market, by application
      7.4.2.3.3. Australia rapid tests market, by end user
    7.4.2.4. India
      7.4.2.4.1. India rapid tests market, by product
      7.4.2.4.2. India rapid tests market, by application
      7.4.2.4.3. India rapid tests market, by end user
    7.4.2.5. South Korea
      7.4.2.5.1. South Korea rapid tests market, by product
      7.4.2.5.2. South Korea rapid tests market, by application
      7.4.2.5.3. South Korea rapid tests market, by end user
    7.4.2.6. Rest of Asia-Pacific
      7.4.2.6.1. Rest of Asia-Pacific rapid tests market, by product
      7.4.2.6.2. Rest of Asia-Pacific rapid tests market, by application
      7.4.2.6.3. Rest of Asia-Pacific rapid tests market, by end user
  7.4.3. Asia-Pacific rapid tests market, by product
  7.4.4. Asia-Pacific rapid tests market, application
  7.4.5. Asia-Pacific rapid tests market, by end user
7.5. LAMEA
  7.5.1. Key market trends, growth factors, and opportunities
  7.5.2. Market size and forecast, by country
    7.5.2.1. Brazil
      7.5.2.1.1. Brazil rapid tests market, by product
      7.5.2.1.2. Brazil rapid tests market, by application
      7.5.2.1.3. Brazil rapid tests market, by end user
    7.5.2.2. Saudi Arabia
      7.5.2.2.1. Saudi Arabia rapid tests market, by product
      7.5.2.2.2. Saudi Arabia rapid tests market, by application
      7.5.2.2.3. Saudi Arabia rapid tests market, by end user
    7.5.2.3. South Africa
      7.5.2.3.1. South Africa rapid tests market, by product
      7.5.2.3.2. South Africa rapid tests market, by application
      7.5.2.3.3. South Africa rapid tests market, by end user
    7.5.2.4. Rest of LAMEA
      7.5.2.4.1. Rest of LAMEA rapid tests market, by product
      7.5.2.4.2. Rest of LAMEA rapid tests market, by application
      7.5.2.4.3. Rest of LAMEA rapid tests market, by end user
  7.5.3. LAMEA rapid tests market, by product
  7.5.4. LAMEA rapid tests market, application
  7.5.5. LAMEA rapid tests market, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Akers Biosciences, Inc.
  8.1.1. Company overview
  8.1.2. Company snapshot
  8.1.3. Operating business segments
  8.1.4. Product portfolio
  8.1.5. Business performance
8.2. Abbott Laboratories (Alere Inc.)
  8.2.1. Company overview
  8.2.2. Company snapshot
  8.2.3. Operating business segments
  8.2.4. Product portfolio
  8.2.5. Business performance
8.3. Becton, Dickinson and Company
  8.3.1. Company overview
  8.3.2. Company snapshot
  8.3.3. Operating business segments
  8.3.4. Product portfolio
  8.3.5. Business performance
  8.3.6. Key strategic moves and developments
8.4. Bio-Rad Laboratories, Inc.
  8.4.1. Company overview
  8.4.2. Company snapshot
  8.4.3. Operating business segments
  8.4.4. Product portfolio
  8.4.5. Business performance
8.5. Danaher Corporation (Cepheid, Inc.)
  8.5.1. Company overview
  8.5.2. Company snapshot
  8.5.3. Operating business segments
  8.5.4. Product portfolio
  8.5.5. Business performance
8.6. Hologic, Inc.
  8.6.1. Company overview
  8.6.2. Company snapshot
  8.6.3. Operating business segments
  8.6.4. Product portfolio
  8.6.5. Business performance
8.7. Meridian Bioscience, Inc.
  8.7.1. Company overview
  8.7.2. Company snapshot
  8.7.3. Operating business segments
  8.7.4. Product portfolio
  8.7.5. Business performance
8.8. OraSure Technologies, Inc.
  8.8.1. Company overview
  8.8.2. Company snapshot
  8.8.3. Operating business segments
  8.8.4. Product portfolio
  8.8.5. Business performance
8.9. Quidel Corporation
  8.9.1. Company overview
  8.9.2. Company snapshot
  8.9.3. Operating business segments
  8.9.4. Product portfolio
  8.9.5. Business performance
8.10. F. Hoffmann-La Roche AG (Roche Diagnostics)
  8.10.1. Company overview
  8.10.2. Company snapshot
  8.10.3. Operating business segments
  8.10.4. Product portfolio
  8.10.5. Business performance

List Of Tables

LIST OF TABLES

TABLE 01. GLOBAL RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 02. OVER-THE-COUNTER (OTC) RAPID TESTS PRODUCTS MARKET, BY REGION, 20162023 ($MILLION)
TABLE 03. PROFESSIONAL RAPID TESTS PRODUCTS MARKET, BY REGION, 20162023 ($MILLION)
TABLE 04. GLOBAL RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 05. RAPID TESTS MARKET FOR INFECTIOUS DISEASE, BY TYPE, 20162023 ($MILLION)
TABLE 06. INFECTIOUS DISEASE RAPID TESTS MARKET, BY REGION, 20162023 ($MILLION)
TABLE 07. RAPID TESTS MARKET FOR CARDIOLOGY, BY REGION, 20162023 ($MILLION)
TABLE 08. RAPID TESTS MARKET FOR ONCOLOGY, BY REGION, 20162023 ($MILLION)
TABLE 09. RAPID TESTS MARKET FOR PREGNANCY & FERTILITY, BY REGION, 20162023 ($MILLION)
TABLE 10. RAPID TESTS MARKET FOR TOXICOLOGY, BY REGION, 20162023 ($MILLION)
TABLE 11. RAPID TESTS MARKET FOR GLUCOSE MONITORING, BY REGION, 20162023 ($MILLION)
TABLE 12. RAPID TESTS MARKET FOR OTHER APPLICATIONS, BY REGION, 20162023 ($MILLION)
TABLE 13. GLOBAL RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 14. RAPID TESTS MARKET FOR HOSPITALS & CLINICS, BY REGION, 20162023 ($MILLION)
TABLE 15. RAPID TESTS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 20162023 ($MILLION)
TABLE 16. RAPID TESTS MARKET FOR HOME CARE, BY REGION, 20162023 ($MILLION)
TABLE 17. RAPID TESTS MARKET FOR OTHERS, BY REGION, 20162023 ($MILLION)
TABLE 18. RAPID TESTS REVENUE, BY REGION, 20162023 ($MILLION)
TABLE 19. NORTH AMERICA RAPID TESTS MARKET, BY COUNTRY, 20162023 ($MILLION)
TABLE 20. U.S. RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 21. U.S. RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 22. U.S. RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 23. CANADA RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 24. CANADA RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 25. CANADA RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 26. MEXICO RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 27. MEXICO RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 28. MEXICO RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 29. NORTH AMERICA RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 30. NORTH AMERICA RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 31. NORTH AMERICA RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 32. EUROPE RAPID TESTS MARKET, BY COUNTRY, 20162023 ($MILLION)
TABLE 33. GERMANY RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 34. GERMANY RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 35. GERMANY RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 36. FRANCE RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 37. FRANCE RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 38. FRANCE RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 39. UK RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 40. UK RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 41. UK RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 42. ITALY RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 43. ITALY RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 44. ITALY RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 45. SPAIN RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 46. SPAIN RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 47. SPAIN RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 48. REST OF EUROPE RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 49. REST OF EUROPE RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 50. REST OF EUROPE RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 51. EUROPE RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 52. EUROPE RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 53. EUROPE RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 54. ASIA-PACIFIC RAPID TESTS MARKET, BY COUNTRY, 20162023 ($MILLION)
TABLE 55. JAPAN RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 56. JAPAN RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 57. JAPAN RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 58. CHINA RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 59. CHINA RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 60. CHINA RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 61. AUSTRALIA RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 62. AUSTRALIA RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 63. AUSTRALIA RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 64. INDIA RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 65. INDIA RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 66. INDIA RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 67. SOUTH KOREA RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 68. SOUTH KOREA RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 69. SOUTH KOREA RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 73. ASIA-PACIFIC RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 74. ASIA-PACIFIC RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 75. ASIA-PACIFIC RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 76. LAMEA RAPID TESTS MARKET, BY COUNTRY, 20162023 ($MILLION)
TABLE 77. BRAZIL RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 78. BRAZIL RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 79. BRAZIL RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 80. SAUDI ARABIA RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 81. SAUDI ARABIA RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 82. SAUDI ARABIA RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 83. SOUTH AFRICA RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 84. SOUTH AFRICA RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 85. SOUTH AFRICA RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 86. REST OF LAMEA RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 87. REST OF LAMEA RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 88. REST OF LAMEA RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 89. LAMEA RAPID TESTS MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 90. LAMEA RAPID TESTS MARKET, BY APPLICATION, 20162023 ($MILLION)
TABLE 91. LAMEA RAPID TESTS MARKET, BY END USER, 20162023 ($MILLION)
TABLE 92. AKERS BIOSCIENCES, INC.: COMPANY SNAPSHOT
TABLE 93. AKERS BIOSCIENCES, INC.: PRODUCT SEGMENTS
TABLE 94. AKERS BIOSCIENCES, INC.: PRODUCT PORTFOLIO
TABLE 95. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 96. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 97. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 98. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 99. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
TABLE 100. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 101. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 102. BIO-RAD LABORATORIES, INC.: PRODUCT SEGMENTS
TABLE 103. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 104. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 105. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 106. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 107. HOLOGIC, INC.: COMPANY SNAPSHOT
TABLE 108. HOLOGIC, INC.: PRODUCT SEGMENTS
TABLE 109. HOLOGIC, INC.: PRODUCT PORTFOLIO
TABLE 110. MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT
TABLE 111. MERIDIAN BIOSCIENCE, INC.: PRODUCT SEGMENTS
TABLE 112. MERIDIAN BIOSCIENCE, INC.: PRODUCT PORTFOLIO
TABLE 113. ORASURE TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 114. ORASURE TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 115. ORASURE TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 116. QUIDEL CORPORATION: COMPANY SNAPSHOT
TABLE 117. QUIDEL CORPORATION: PRODUCT SEGMENTS
TABLE 118. QUIDEL CORPORATION: PRODUCT PORTFOLIO
TABLE 119. F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
TABLE 120. F. HOFFMANN-LA ROCHE AG: PRODUCT SEGMENTS
TABLE 121. F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO

List Of Figures

LIST OF FIGURES

FIGURE 01. GLOBAL RAPID TESTS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2016
FIGURE 04. IMPACT ANALYSIS
FIGURE 05. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER (OTC) RAPID TESTS PRODUCTS MARKET, BY COUNTRY, 2016 & 2023 ($MILLION)
FIGURE 06. COMPARATIVE ANALYSIS OF PROFESSIONAL RAPID TESTS PRODUCTS MARKET, BY COUNTRY, 2016 & 2023 ($MILLION)
FIGURE 07. RAPID TESTS MARKET REVENUE FOR HPV, 20162023 ($MILLION)
FIGURE 08. RAPID TESTS MARKET REVENUE FOR HEPATITIS, 20162023 ($MILLION)
FIGURE 09. RAPID TESTS MARKET REVENUE FOR INFLUENZA, 20162023 ($MILLION)
FIGURE 10. RAPID TESTS MARKET REVENUE FOR MALARIA, 20162023 ($MILLION)
FIGURE 11. RAPID TESTS MARKET REVENUE FOR HIV, 20162023 ($MILLION)
FIGURE 12. RAPID TESTS MARKET REVENUE FOR OTHER INFECTIOUS DISEASES, 20162023 ($MILLION)
FIGURE 13. COMPARATIVE ANALYSIS OF RAPID TESTS MARKET FOR INFECTIOUS DISEASE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF RAPID TESTS MARKET FOR CARDIOLOGY, BY COUNTRY, 2016 & 2023 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF RAPID TESTS FOR ONCOLOGY, BY COUNTRY, 2016 & 2023 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF RAPID TESTS MARKET FOR PREGNANCY & FERTILITY, BY COUNTRY, 2016 & 2023 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF RAPID TESTS MARKET FOR TOXICOLOGY, BY COUNTRY, 2016 & 2023 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF RAPID TESTS MARKET OF GLUCOSE MONITORING, BY COUNTRY, 2016 & 2023 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF RAPID TESTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF RAPID TESTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF RAPID TESTS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2016 & 2023 (%)
FIGURE 22. COMPARATIVE ANALYSIS OF RAPID TESTS MARKET FOR HOME CARE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 23. COMPARATIVE ANALYSIS OF RAPID TESTS MARKET FOR OTHERS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 24. AKERS BIOSCIENCES, INC.: REVENUE, 20152017 ($MILLION)
FIGURE 25. AKERS BIOSCIENCES, INC.: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 26. ABBOTT LABORATORIES: NET SALES, 20152017 ($MILLION)
FIGURE 27. ABBOTT LABORATORIES: NET SALES SHARE BY SEGMENT, 2017 (%)
FIGURE 28. ABBOTT LABORATORIES: NET SALES SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 29. BECTON, DICKINSON AND COMPANY: REVENUE, 20152017 ($MILLION)
FIGURE 30. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 31. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 32. BIO-RAD LABORATORIES, INC.: NET SALES, 20152017 ($MILLION)
FIGURE 33. BIO-RAD LABORATORIES, INC.: NET SALES SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 34. DANAHER CORPORATION: REVENUE, 20152017 ($MILLION)
FIGURE 35. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 37. HOLOGIC, INC.: REVENUE, 20152017 ($MILLION)
FIGURE 38. HOLOGIC, INC.: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 39. HOLOGIC, INC.: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 40. MERIDIAN BIOSCIENCE, INC.: REVENUE, 20152017 ($MILLION)
FIGURE 41. MERIDIAN BIOSCIENCE, INC.: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42. MERIDIAN BIOSCIENCE, INC.: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 43. ORASURE TECHNOLOGIES, INC.: REVENUE, 20152017 ($MILLION)
FIGURE 44. ORASURE TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45. ORASURE TECHNOLOGIES, INC.: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 46. QUIDEL CORPORATION: REVENUE, 20152017 ($MILLION)
FIGURE 47. QUIDEL CORPORATION: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 48. QUIDEL CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 49. F. HOFFMANN-LA ROCHE AG: REVENUE, 20152017 ($MILLION)
FIGURE 50. F. HOFFMANN-LA ROCHE AG: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 51. F. HOFFMANN-LA ROCHE AG: REVENUE SHARE BY GEOGRAPHY,